Vasculitis is a common clinical problem which frequently poses problems both in diagnosis and in management. It is also a fertile ground for research involving a multidisciplinary approach of cell biologists, immunologists and molecular biologists. This meeting was an exciting opportunity to review recent developments some of which are already having a clinical impact.
Dr DO Haskard (Rheumatology Unit, Division of Medicine, United Medical and Dental Schools of Guy's and St Thomas's Hospitals, London) spoke on mechanisms of lymphocyte-endothelial cell interactions. The adhesion of lymphocytes to the surface of endothelial cells (EC) is the first step in their passage into tissues during inflammation. As part of a review of possible pathogenetic factors underlying the various forms of vasculitis it is worth considering the possibility that mechanisms by which lymphocytes adhere to EC during inflammation may under pathological conditions be damaging to the blood vessel involved.
There is considerable evidence from in vitro experiments that the adhesiveness of EC for lymphocytes is increased by cytokines. These fall into two groups: IL-1 l and TNF2 have peak actions at 8-10 h following stimulation and also enhance EC adhesiveness for neutrophils and monocytes", In contrast, the lymphokines IFN'}'4 and IL4 (Thornhill et al., submitted) have an optimal effect at 18-24 h and appear to be selective for lymphocyte adhesion. It is therefore possible to create a model in which the release of these and perhaps other factors locally has a feedback effect on EC that results in the further adhesion and recruitment of lymphocytes and other leukocyte types into inflammatory lesions. As EC themselves secrete IL-1 5 and vascular smooth muscle cells secrete IL-1 6 and TNF7 these events could take place in the vessel wall itself in a vasculitic focus.
Peripheral blood T cells are well known to be of heterogeneous phenotype. Preliminary experiments had demonstrated that they are also heterogeneous with respect to the capacity to adhere to EC, but that this could not be accounted for by differences in adhesiveness of conventional helper CD4 and suppressor/cytotoxic CD8 T cells". Observations, however, that NK cells" and memory T cells'? adhere preferentially to EC may well be relevant to involvement of 'natural immunity' and 'specific immunity' in the pathogenesis of vasculitis. T J Williams then spoke on leucocyte-endothelial cell interactions in vitro. (Summary manuscript submitted with C von Uexkull and S Nourshargh, Department of Applied Pharmacology, National Heart and Lung Institute, London). In an inflammatory reaction, chemical mediators are generated that have the essential role of stimulating the local accumulation ofleukocytes. Neutrophil chernoattractants increase leukocyte motility and induced chemotaxis in various simple in vitro test systems, but clearly the mechanisms involved in cell accumulation in vivo are complex. In this respect, most is known about the predominant cell that appears in acute inflammatory reactions, the neutrophil.
The critical first stage in neutrophil emigration is their attachment to the endothelium. In most tissues this occurs in the small venules. This is followed by passage through inter-endothelial cell junctions and then through the perivascular basement membrane.
Neutrophils have receptors for certain mediators, eg C5a, f-met-leu-phe (FMLP) and leukotriene B4. These substances have potent effects on neutrophils in vitro and they stimulate neutrophil emigration in vivo, eg when injected intradermally. The most convenient theory to explain the in vivo effects of such mediators is that they diffuse into the lumen of the microvessel, and increase the adhesiveness of the leukocyte membrane such that it adheres to the endothelium. This is supported by a recent study in the hamster cheek pouch!'. Whether these mediators act by increasing the adhesiveness of the endothelium is contentious. Some workers have reported such an effect in vitro l2.l3, ie after addition of mediators to endothelial cells and washing, neutrophils stick more avidly. Other workers have reported that this is caused by inadequate washing of the endothelium after application of the mediator-s, It has also been reported that in rabbit skin in vivo, skin sites can be selectively desensitized to a given mediator by repeated injections into the same site l5. This suggests an effect of the mediators on the endothelium in vivo.
Interleukin-I (IL-1) induces neutrophil accumulation in vivo l6.l7 but it appears that the IL·1 is not chemotactic for neutrophils in vitro. There is, however, strong evidence for a direct effect ofIL-1 on the endothelium in vitro. It has been shown that the IL-1 induces an increase in adhesiveness of cultured endothelial cells, by a slow process dependent on protein synthesis'", Considerable progress has been made in understanding the nature of the cell surface molecules expressed on leukocytes and endothelial cells that are involved in adherence l9-2l. Certain rare individuals lack some of the leukocyte surface components and their neutrophils and monocytes are unable to emigrate. These individuals suffer from recurrent infections. In the neutrophil the complex defined as CDllb/CD18 (Mac-I) appears to be important for adherence. Monoclonal antibodies recognizing the CD18 antigen, such as MoAb 60.3 do not bind to neutrophils from the affected individuals. Normal neutrophils show a basal expression of Mac-1 and this increases when stimulated with chemoattractants such as FMLP in vitro. Using lllIn·labelled neutrophils injected intravenously in rabbits, and intradermally-injected mediators, the authors have been studying mechanisms involved in neutrophil accumulation in vivo. Others have shown that intravenous injection of MoAb 60.3 blocks neutrophil emigration in response to chemoattractants'" and it has been suggested that neutrophils increase their expression of Mac-I in vivo in order to attach to the endothelium. The authors have found, however, that pre-incubation of lllln-neutrophils with MoAb 60.3 in vitro to block basally-expressed Mac-1 also blocks their emigration in vivo when injected intraven-ously23. This suggests that increased adherence to endothelial cells in vivo is a consequence of a conformational change in basally-expressed Mac-1, rather than increase expression. These in vivo observations are supported by reports from in vitro experiments 24,25. The differences observed between the effects of chemoattractants and IL-1 in vitro are also reflected in results obtained in vivo. Thus, the authors have shown that CD5a induces a fast protein synthesisindependent neutrophil accumulation in rabbit skin, whereas in contrast, IL-1 induces a slow protein synthesis-dependent neutrophil accumulation!".
Neutrophil accumulation is closely associated with the other characteristic features of acute inflammation. Chemoattractants such as C5a are potent inducers of oedema formation in rabbit skin 26, 27 and this effect can be abolished by depleting circulating neutrophils'". Thus, the rapid interaction between neutrophils and endothelial cells triggered by chemoattractants in some way leads to plasma protein leakage from microvessels. This effect is enhanced in the presence of vasodilator prostaglandins or neuropeptides such as VIP and CGRp28-30. The mechanisms underlying increased microvascular permeability induced by neutrophils are at present under investigation. D Male spoke on lymphocyte interactions with cerebralendothelium. (Summary manuscript submitted with G Pryce and J Rahman, Department of Neuropathology, Institute of Psychiatry, London). Brain endothelium differs from other endothelia due in part to its continuous tight junctions and specialized transport systems, which contribute to the bloodbrain barrier. It is also particularly important in controlling the development of immune reactions in the CNS. Lymphocyte traffic into the CNS is normally very limited, although it can increase dramatically during immune reactions to CNS tissues or in response to infection. In these studies the authors have used brain endothelium in vitro to answer the following questions:
(1) How does brain endothelium respond to cytokines?
(2) What factors control lymphocyte traffic into CNS?
(3) Does cerebral endothelium differ functionally from extracerebral endothelium in the ways it can interact with lymphocytes? (4) Can it act as an antigen presenting tissue?
The experimental work has been carried out using pure monolayers of cerebral endothelium and aortic endothelium from rat, which retain their physiclogical characteristics and surface markers in vitro.
Brain endothelium responds rapidly to low levels of TNFa and IFNT by enhanced MHC Class I expression. IFN T when present at high levels for an extended period (> 48 h) can also induce MHC Class II expression. TNF does not induce MHC Class II although it does synergize with IFN T in this respect. The resting and enhanced levels of expression ofMHC Class I are similar on cerebral and extracerebral endothelium, but Class II is induced to much greater levels on cerebral endothelium, equivalent cytokin concentrations.
The inducibility of Class II on brain endothelium varies depending on the strain of animal tested. Strains which are more sensitive to Class II induction are more susceptible to the induction of experimental allergic encephalomyelitis (EAE). However, this effect is not specific for brain endothelium since class II is also more readily induced on astrocytes and a variety of other cells in EAE susceptible strains.
Rat brain endothelium can present antigen, but it is a poor stimulator of T cell proliferation due to its high level of eicosanoid production, but there appears to be considerable variation in this function depending on the antigens used and in different species.
At least three factors control the adhesion of lymphocytes to brain endothelium, of which the first two are more important.
(a) Cytokine-induced induction of adhesion molecules on the endothelium. The basal level of lymphocyte binding to brain endothelium is about 20% of that seen binding to extracerebral endothelium. This may explain why there is low lymphocyte traffic into normal brain. Nevertheless brain endothelium is exquisitely sensitive to cytokines, responding with a rapid synthesis of adhesion molecules, which now can bind lymphocytes by a CD18 dependent mechanism. Lymphocyte activation further increases their adhesiveness for the endothelium, with receptors on the lymphocytes being strongly expressed during the early stages of the cell cycle. B cells and CD8+ T cells adhere preferentially to cytokine-activated endothelium.
F J van der Woude spoke on the development and diagnostic use ofassays for anti-neutrophil cytoplasmic antibodies (ANCA); implications for the pathogenesis of Wegener's granulomatosis. (Summary manuscript submitted with L A van Es and M R Daha, Department of Nephrology, State University Hospital, Leiden, The Netherlands.) Generalized Wegener's granulomatosis (WG) is characterized by necrotizing granulomatous vasculitis of the upper airways and lungs, together with focal proliferative glomerulnephritis 31,32. In 1985 we described the occurrence of auto-antibodies directed against cytoplasmatic constituents of neutrophils and monocytes in sera obtained from WG patients'". In this paper the auto-antibody nature of ACPA (later on renamed as ANCA) was formally proven as well as its specificity for the disease. Moreover, antibody titres correlated with disease activity. Our findings have been confirmed by several other groups34-37. In addition, a second antibody was discovered by Ron Falk and Charles Jennette in the USA that stains the cytoplasm of ethanol-fixed granulocytes in a perinuclear pattern'", Therefore, this staining pattern is referred to as pANCA (=perinuclear ANCA) whereas the first staining pattern is now called cANCA (=classic ANCA)39. A third system in which IgA·ANCA react with an acidic extract of neutrophils was discovered in Henoch-Schonlein patients'". IgM-ANCA are found in a subgroup of patients with pulmonary haemorrhage and rapidly progressive glomerulonephritis".
Although the immunofluorescence test remains the golden standard for ANCA detectiorr'P, various groups have started to develop solid phase assays to facilitate rapid reading and quantification. The first publication on the application of a solid phase ANCA assay reported on a radioimmunoassay with acid extract from sonicated granulocytes as antigen preparations". Other methods that have been reported make use of antigen preparations isolated with immunoaffinity chromatography'", Percoll gradient centrifugation of nitrogenbomb cavitated material-s and granulocyte lysis by sucrosev'. The isolation of the target antigen for cANCA has still not advanced far enough to allow any final conclusion. It is most probably a 29 kD serine protease localized within the alpha granula of the granulocyte that shows some homology to proteinase 3 45.46. Interestingly, cANCA positive sera and mouse monoclonal antibodies directed against the cANCA antigen, recognize a 91 kD antigen in sputum or supernatant of neutrophils after pokeweed mitogen stimulatiorr'", Finally, Sandwich-ELISA systems using goat-anti mouse and a mouse monoclonal against 29 kD antigen for antigen catching and subsequent incubation with patient serum and anti-human Ig antibodies have been reported",
In order to obtain information on the reproducibility of the various assays which are currently employed for ANCA detection, the authors sent eight well characterized serum samples to 13 laboratories participating in the second workshop on ANCA in May 1989, in Noordwijkerhout, The Netherlands.
The conclusions of this study were that problems still arise when cANCA and pANCA serum samples with a relatively weak activity were assessed. It seems therefore that the standard immunofluorescence method for ANCA 42 remains the assay of choice for the assessment of antineutrophil cytoplasm antibodies as the present solid phase assays require further improvement and standardizatiorr'".
The positive correlation between cANCA titre and disease activity changes suggests that the appearance of cANCA in WG is more than just an epiphenomenon. Friedrich Wegener himself already postulated that a microbial infection or hyperreaction to some extrinsic agent was the cause of the disease 5o. Most relapses of WF occur at the time of infection with common pathogens'". It has been claimed that antibiotic therapy with sulphamethoxazole-trimethoprim has a beneficial effect on the course of the disease 52. So if infection in the respiratory tract may be the trigger for the initiation of relapses, it may do so because it causes the release of myeloid lysosomal enzymes that elicit a humoral and cellular autoimmune response. Widespread tissue necrosis is a major characteristic of the disease. Since cANCA may bind to both a 29 kD serine protease from within the neutrophil and to a 91 kD antigen from neutrophil supernatant or sputunr'", it is attractive to speculate that cANCA may bind to both the proteinase and to the complex formed by the proteinase and its inhibitor. Proteinase-antibody complexes may be protected against inactivation by proteinase-inhibitors and transported through the body to other areas, such as the kidneys. If the proteinases in these complexes retain their enzymatic activity, they might then cause local damage. The authors have shown 53 that T lymphocytes from patients with WG are stimulated to proliferate by the 29 kD and 91 kD cANCA antigens in contrast to lymphocytes from healthy controls. In the light of these finding it is attractive to speculate that T cells directed against the cANCA antigen might invade lesions which contain proteinase-antibody complexes. The presence of tissue necrosis and such proteinaseantibody complexes might then induce granuloma formation. R J Falk discussed the association between myeloperoxidase specific anti-neutrophil cytoplasmic autoantibodies and renal disease. (Summary manuscript prepared with J C Jennette, The University of North Carolina, Chapel Hill). ANCA are found in the circulation of patients with a spectrum of disease ranging from pauci-immune necrotizing and crescentic glomerulonephritis to systemic necrotizing vasculitis (eg polyarteritis nodosa and Wegener's granulomatoaisj'vs". ANCA are specific for constituents of neutrophil primary granules and monocyte lysosomes. Two different ANCA staining patterns specificities have been found by indirect immunofluorescence microscopy: cytoplasmic (C-ANCA) and artifactual perinuclear (P-ANCA)54-57. In patients with vasculitis or glomerulonephritis, 90% of P-ANCA are specific for myeloperoxidase (MPO); whereas most C-ANCA are specific for proteinase 3 56,58. P-ANCA in other types of inflammatory disease (eg ulcerative colitis) are specific for neutrophil constituents other than MPO.
In patients with active necrotizing glomerulonephritis and vasculitis, both C-ANCA or P-ANCA are found in over 80%55. Some patients with ANCA have renal-limited disease, whereas others have systemic vasculitis. In patients with renal-limited disease, MPO-specific P-ANCA is more frequent than C-ANCA. ANCA-associated glomerulonephritis is characterized by no or scanty immune deposits, necrosis, and crescent formation. In contrast less than 5% of patients with immune complex-mediated glomerulonephritis or other renal diseases have ANCA. Except for rare occasions, patients with anti-GBM disease do not have ANCA.
The two ANCA patterns are distinguished by indirect immunofluorescence microscopy using alcohol-fixed neutrophils as a substrate'". C-ANCA produce cytoplasmic staining of neutrophils while P-ANCA cause perinuclear staining. This artificial nuclear staining results from the specificity of P-ANCA for nucleophilic cytoplasmic antigens that artifactually redistribute around the nucleus during preparation of the alcohol-fixed substrate. If the neutrophils are exposed to a cross-linking fixative, such as formalin, these granule constituents remain in their granules. Thus, formalin-fixed neutrophils, when used as a substrate for indirect immunofluorescence identification of ANCA, demonstrate that both C-ANCA and P-ANCA produce identical cytoplasmic staining patterns. That P-ANCA in patients with vasculitis and glomerulonephritis are usually reactive with MPO has been determined by ELISA and Western Blot analysis 54 • 56. The authors have also been able to block this P-ANCA immunostaining pattern with monoclonal antibodies to MPO. P-ANCA that are not specific for MPO may react with other neutrophils constituents, such as elastase 56 and lactoferrins'', C-ANCA and MPO-ANCA are found in patients with renal-limited disease, as well as those with necrotizing glomerulonephritis associated with polyarteritis nodosa and Wegener's granulomatosis. The authors have evaluated the clinical features and response to treatment in a prospective study of a cohort of 70 patients with pauci-immune necrotizing glomerulonephritis and either C-ANCA or MPO-ANCA55. 60 . Most ofthese patients have had a flu-like prodrome prior to the onset of glomerulonephritis or vasculitis; and the onset disease is significantly lower in the summer. Of these 70 patients, 25% have had renal-limited disease, and 50% pulmonary disease. A third of these latter patients have had concomitant upper and lower respiratory tract disease. Overall, an equal percentage patients have had C-ANCA or MPO-ANCA within groups of patients with organ involvement for a specific tissue, except for patients with sinus involvement who have a high frequency of C-ANCA. For example, there is an equivalent distribution of MPO-ANCA and C-ANCA in patients with pulmonary disease, gastrointestinal disease, renal disease and neurological disease.
Differences between ANCA phenotypes are found, however, when patients are grouped together into certain clinical pathological syndromes. For example, patients with renal-limited disease have a higher frequency of MPO-ANCA, whereas those with concomitant sinus and lung disease have a higher incidence of C-ANCA. After a mean of 24 months follow-up there are no differences in these 70 patients in renal and patient survival relative to C-ANCA or MPO-ANCA patients.
ANCA, including MPO-ANCA, may prove to be directly involved in the pathogenesis of inflammatory vascular injury. The authors have shown that both C·ANCA and MPO-ANCA IgG induce cytokineprimed neutrophils to produce a respiratory burst and to degranulate 61.62. By fluorescent activated cell sorter analysis, the authors have observed that cytokine priming results in the expression of ANCA antigens at the cell surface where these antigens can react with ANCA to induce leukocyte activation. It is the authors' hypothesis that circulating ANCA recognize their antigens after these proteins have been mobilized from primary granules to the cell surface. This process is triggered in vitro by cytokineinduced leukocyte priming. In vivo, the flu-like prodrome and seasonal variations suggest that synergistic infections may serve as an in vivo leukocyte priming event in patients who have ANCAassociated diseases.
In conclusion, ANCA of both C·ANCA and MPO-ANCA varieties are excellent serological markers that define a category ofcrescentic glomerulonephritis and vasculitis separate from those diseases caused by immune-complex deposition or anti-glomerular basement antibodies. The clinical disease distribution ofC-ANCA is found more frequently in patients with concurrent sinus, lung, and renal involvement (ie Wegener's granulomatosie)", whereas MPO·ANCA is found more frequently in patients with renallimited disease. ANCA of both types may be involved in the pathogenesis of immune vascular injury. various disorders revealed that ANCA were found in > 95% of the cases of WG that are in the acute generalized phase, but also in the active initial phase in >60% of the cases. However, ANCA were only found in 24 cases of the controls (mainly unclassified vasculitis), demonstrating the high specificity of ANCA for WG. Moreover the authors could show that ANCA titre changes parallel changes in disease activity and help to distinguish relapses ofWG from other intercurrent illnesses, mainly infections, which are always a threat to patients on immunosuppressive treatments", Therefore, ANCA are not only valuable seromarker for WG but are also very useful for monitoring disease activity.
The correlation between ANCA titre and disease activity changes suggests between ANCA titre and disease activity changes suggests that the role of ANCA is more than just that of an epiphenomenon. Therefore, identification of the target antigen of ANCA is of crucial importance for further investigations into the pathogenesis ofWG. Characterization of the ANCA antigen was done with antigen isolated by affinity chromatography from supernatants of human neutrophils, stimulated with phorbol ester to induce degranulation. SDS-PAGE under reducing conditions revealed that the affinitypurified antigen comprises of at least three isoforms of molecular weight 26 kD to 28 kD. In immunoblotting, reaction of ANCA·positive sera was only observed when the antigen was separated under non-reducing conditions, indicating that the autoantibodies are directed against a conformational epitope of the protein. Investigation of the enzymatic activity showed that the antigen is an elastinolytic neutral serine proteinase, whose features are identical with those of the recently described proteinase 3, an enzyme that is capable of inducing experimental emphysema'". Therefore, it is concluded that ACPA are directed against a conformational epitope of proteinase 3 65.
To investigate the distribution of the target antigen of ACPA within the organelles of resting normal polymorphonuclear leukocytes and monocytes, the authors used immunocytochemical techniques on thin frozen sections. These studies were done in collaboration with Dr Dorothy F Bainton (San Francisco). To obtain valuable tools for immunolabelling, two murine monoclonal antibodies directed against the ACPA antigen were established. Using these monoclonal antibodies we could demonstrate that the antigen is located mainly within large myeloperoxidase-positive azurophil granules of human neutrophils and also in small cytoplasmic granules of monocytes'". In addition smaller amounts of the antigen are expressed on the plasma membrane of both cell types, becoming thereby accessible to the circulating autoantibodies. Therefore, binding of ACPA in vivo could result in cell activation and degranulation, which might lead to tissue destruction. C M Lockwood spoke on new approachesto therapy in systemic vasculitis. (Summary manuscript submitted with D R W Jayne, Department of Medicine, Clinical Medical School, Addenbrooke's Hospital, Cambridge). The treatment of systemic vasculitis has evolved empirically to include steroids in combination with cyclophosphamide. Although successful at including remission in most patients, problems arise due to drug toxicity, immunosuppression and the long-term control of disease activity. The spectrum of systemic vasculitis is much wider than 'classical' Wegener's granulomatosis, for which this therapy was designed, and new serological markers, such as antineutrophil cytoplasm antibodies (ANCA), are reo classifying these conditions", Also, the natural history of ANCA positive, restricted forms of vasculitis is undetermined and likely to be different from that for Wegener's granulomatosis.
Of the current alternatives to standard treatment, the largest experience has been with trimethoprim/ sulphamethoxazole (TIS). There are uncontrolled reports totalling over 60 patients, when given with or without standard therapy, with variable degrees of benefit ascribed to TIS. Such effects appeared after an average of four weeks, but no satisfactory therapeutic mechanism has been proposeds". A useful result with cyclosporin A has been reported occasionally, but our experience with this drug in eight patients has not been promising.
Monoclonal antibody therapy, now established in oncology and the management of graft rejection, holds exciting prospects for therapy in autoimmunity, through its potential specificity for particular components of the immune response. In a single patient study, lasting remission was achieved in the face of resistance to conventional drugs by injection of Campath 1 (anti-Tcell, B-cell and macrophage) and anti·CD4 monoclonals (P W Mathieson, personal communication).
A controlled study of plasma exchange plus steroids and cyclophosphamide conferred a therapeutic advantage over drugs alone, in patients with severe renal involvements". In order to throw light on the mechanism of this effect, the authors used plasma exchange as sole therapy in four patients with ANCA positive systemic vasculitis. Following treatment all went into clinical remission and circulating ANCA dropped to background. This response is in marked contrast to anti-glomerular basement membrane disease where an autoantibody rebound occurs in the absence of immunosuppressive drugs. Therefore plasma exchange appears to influence the immunoregulatory abnormalities in vasculitis. Extra-corporeal immunoabsorption with protein A, in small numbers so far, may be less immunosuppressive and more efficient at removing IgG than plasma exchange.
There is growing evidence that ANCA contributes to the pathogenesis of vasculitis. This comes from the association of ANCA titre and isotype with disease expression, the cross-reactivity of ANCA with glomerular and endothelial targets and the effect of ANCA on neutrophil activation, signal transduction and interaction with neutrophil enzymes. The authors found anti-idiotypes to ANCA in pooled, normal, human immunoglobulin (IVIg, Sandoz) and in the sera of patients who have recovered from vasculitis; and suggest that idiotype/anti-idiotype interactions are important in the physiological control of autoreactivity in vasculitis 69 • In a pilot study of IVIg in four patients, two resistant to conventional drugs and two on no treatment, all four had clinical improvement with a marked reduction of ANCA in three. The importance of IVIg as an alternative or additional treatment is being determined by further study. These effects of plasma exchange and Mg may induce the same changes as occurred with spontaneous remission, which we have observed in a patient on no treatment when it was associated with loss of ANCA and the appearance of ANCA antiidiotypes.
In conclusion, systemic vasculitis defines a spectrum of autoimmune disease, in which recent discoveries have pointed to a re-classification and have given important insights into pathogenesis. Current treatment is inadequate, and further knowledge of the underlying immunoregulatory abnormalities is required for a rational approach to therapy. Some therapeutic alternatives have been reviewed here and it is speculated that the future will see a change in emphasis from non-specific suppression of immune response to targeted correction of such immunoregulatory abnormalities. The first session of this one-day meeting was devoted to head injuries and facial trauma and the second to the chest and abdomen. The third included trauma imaging in Holland and the pelvis and the fourth the spine. The papers presented fell roughly into three categories; general reviews of the subject, illustrated with examples from the speaker's own work; rather more idiosyncratic reports based on the speaker's particular experience and viewpoint; and a review of the principles involved in setting up an imaging service for a trauma centre.
G S Panayi
Into the first category fell the 'head injury' contributions. Mr R V Jeffreys (Liverpool)gave the neurosurgical view. Initially, in the Accident & Emergency Department, triage had to be made, and plain skull X-rays still had an important place in the assessment of minor head injuries. For the more seriously injured, after resuscitation of the pulmonary and cardiovascular systems the next important factor was the early detection of intracranial haematomas, and here the computerized tomography (Cn scan had a very major role. A district general hospital (DGH) with CT could discuss the findings with the neurosurgical centre (at best using an imaging transfer system) such that the best possiblemanagement could be evolved for the patient. A DGH without a CT could discuss the patient with the neurosurgeona along the guidelines that had been promulgated for discussion or transfer.
Dr W 8t C Forbes (Hope Hospital, Manchester) described CT findings in BOrne detail emphasizing the necessity for follow-up studies. The aim was rapid detection offocal haemorrhage amenable to surgical removal. Large numbers of patients required careful case selection; skull X-rays were useful in finding fractures. He described the findings in extradural, subdural and intracerebral haemorrhage. Although the first of these was usually associated with overt fracture, the others were commonly not. Cerebral oedema could create diagnostic problems. Magnetic resonance imaging (MRI)showed haematoma better so improving prognosis but long scan times and difficulty of access to the machine could present problems.
In the discussion it transpired that contrast enhancement of the CT had been known to produce deterioration although it might be useful in the less acute type of subdural haematoma. MRI did not show extracerebral collections any better than CT. The present generation of telephone image transmission 
